Synthesis, antitumor, and apoptosis-inducing activities of novel 5-arylidenethiazolidine-2,4-dione derivatives: Histone deacetylases inhibitory activity and molecular docking study-Reference-Cited by-同舟云学术

Synthesis, antitumor, and apoptosis-inducing activities of novel 5-arylidenethiazolidine-2,4-dione derivatives: Histone deacetylases inhibitory activity and molecular docking study

Published:2022-12 Issue: Volume:244 Page:114827
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Hamdi Abdelrahman,Elhusseiny Walaa M.,Othman Dina I.A.,Haikal Abdullah,Bakheit Ahmed H.,El-Azab Adel S.,Al-Agamy Mohamed H.M.,Abdel-Aziz Alaa A.-M.^ORCID

Funder

Deanship of Scientific Research, King Saud University

King Saud University

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference76 articles.

1. Cancer prevention from the perspective of global cancer burden patterns

2. Current medicinal chemistry;Li;Anti-cancer agents,2005

3. The New Era in Cancer Research

4. Cardiorespiratory fitness, physical activity and cancer mortality in men

5. Kinase and BET Inhibitors Together Clamp Inhibition of PI3K Signaling and Overcome Resistance to Therapy

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, Synthesis, and Characterization of Novel Thiazolidine-2,4-Dione-Acridine Hybrids as Antitumor Agents;Molecules;2024-07-18

2. Chitosan-enclosed SLN improved SV-induced hepatocellular cell carcinoma death by modulation of IQGAP gene expression, JNK, and HDAC activities;Molecular Biology Reports;2024-07-18

3. Novel quinazolin-2-yl 1,2,3-triazole hybrids as promising multi-target anticancer agents: Design, synthesis, and molecular docking study;Bioorganic Chemistry;2024-07

4. In-silico Binding, Stability, Pharmacokinetics, and Toxicity Studies on Natural (-)-ambrox Metabolites as Binding Ligands to Luminal B and Triple-negative/basal-like Proteins for Breast Cancer Therapy;Letters in Drug Design & Discovery;2024-07

5. Design, synthesis, and in vitro biological evaluation of novel HDAC inhibitors bearing C-1 phenyl substituted tetrahydroisoquinoline Cap moiety as anti-tumor therapeutic agents;Medicinal Chemistry Research;2024-03-27